Amgen Announces Webcast of 2013 First Quarter Financial Results

       Amgen Announces Webcast of 2013 First Quarter Financial Results

PR Newswire

THOUSAND OAKS, Calif., April 18, 2013

THOUSAND OAKS, Calif., April 18, 2013 /PRNewswire/ --Amgen (NASDAQ:AMGN)
today announced that it will report its first quarter financial results on
Tuesday, April 23, 2013, after the close of the U.S. financial markets. The
announcement will be followed by a conference call with the investment
community at 2:00 p.m. Pacific Daylight Time. Participating in the call from
Amgen will be Robert A. Bradway, chairman and chief executive officer, and
other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the
Internet and will be available to members of the news media, investors and the
general public.

The webcast of the conference, as with other selected presentations regarding
developments in Amgen's business given by management at certain investor and
medical conferences, can be found on Amgen's website, www.amgen.com, under
Investors. Information regarding presentation times, webcast availability and
webcast links are noted on Amgen's Investor Relations Events Calendar. The
webcast will be archived and available for replay for at least 30 days after
the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe, effective
medicines from lab to manufacturing plant to patient. Amgen therapeutics have
changed the practice of medicine, helping millions of people around the world
in the fight against cancer, kidney disease, rheumatoid arthritis, bone
disease and other serious illnesses. With a deep and broad pipeline of
potential new medicines, Amgen remains committed to advancing science to
dramatically improve people's lives. For more information, visit www.amgen.com
and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

SOURCE Amgen

Website: http://www.amgen.com
 
Press spacebar to pause and continue. Press esc to stop.